Statin use and the presence of microalbuminuria. Results from the ERICABEL trial: a non-interventional epidemiological cohort study.
<h4>Background</h4>Microalbuminuria (MAU) is considered as a predictor or marker of cardiovascular and renal events. Statins are widely prescribed to reduce cardiovascular risk and to slow down progression of kidney disease. But statins may also generate tubular MAU. The current observat...
Enregistré dans:
Auteurs principaux: | Arjan van der Tol, Wim Van Biesen, Steven Van Laecke, Kris Bogaerts, Koen De Lombaert, Hans Warrinnier, Raymond Vanholder |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3003a43713334de682f2019fb67f4a28 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Genomic and metabolomic profile associated to microalbuminuria.
par: Vannina G Marrachelli, et autres
Publié: (2014) -
Aortic Stiffness Index And Carotid Intima-Media Thickness Are Independently Associated With The Presence Of Microalbuminuria In Patients With Type 2 Diabetes Mellitus
par: Turan Y, et autres
Publié: (2019) -
Synthetic molecular recognition nanosensor paint for microalbuminuria
par: Januka Budhathoki-Uprety, et autres
Publié: (2019) -
Association Between Neck Circumference and Microalbuminuria in Community Residents
par: Jian C, et autres
Publié: (2021) -
The prognostic value of microalbuminuria in puppies with canine parvoviral enteritis
par: Oikonomidis Ioannis L., et autres
Publié: (2019)